Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women

• Main Authors: Tran A., Best B., Stek A., Wang J., Capparelli E., Burchett S., Kreitchmann R., Rungruengthanakit K., George K., Cressey T., Chakhtoura N., Smith E., Shapiro D., Mirochnick M., Buschur S., Jackson C., Paul M., McGregor D., Yogev R., Kalra R., Florez C., Bryan P., Stone M., Hull A., Caffery M., Spector S., Wilson J., Giner J., Donnelly M., Cooper E., McLaud D., Tucker L., Hitti J., Robson-Nuss A., Melvin A., Keller M., Bolaris M., Hayes J., Kamer F., Spencer L., Homans J., Metz T., Wallace J., Katai A., Aziz M., McNichols M., Schmidt J., Wara D., Maka K., Cohan D., Deveikis A., Batra J., Alvarez J., Carter M., Deville J., Janzen C., Gutierrez J., Cavallo M., Purswani M., Knapp K., Sublette N., Wride T.
• 格式: 雜誌
• 出版: 2017
• 在線閱讀: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84959196606&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/41787
• 機構: Chiang Mai University

© Copyright 2016 Wolters Kluwer Health, Inc. All rights reserved. Background: Rilpivirine pharmacokinetics is defined by its absorption, distribution, metabolism, and excretion. Pregnancy can affect these factors by changes in cardiac output, protein binding, volume of distribution, and cytochrome P...